✓
Holistic Program, Not Just a Shot 

✓
Expert Guidance 

✓
Science‑Backed Results 

✓
Long‑Term Support 

1.
Evaluation & Eligibility 

We begin with a comprehensive evaluation, including BMI, metabolic testing and lab work. Your clinician determines whether a GLP‑1 medication is appropriate.

2. 
Medication Initiation & Titration 

You receive a personalized prescription plan. We guide you through dose escalation and help manage common side effects like nausea or GI discomfort. 

3.
Ongoing Support & Habit Change 

Regular tele‑health check‑ins monitor your progress and adjust your prescription. Nutrition and lifestyle coaching help you develop sustainable habits so you keep the weight off.

How It Works

Prescription & Monitoring

Access to Wegovy®, Ozempic®, Mounjaro® or ZepBound™, prescribed when clinically appropriate and supervised by Mayo Clinic–trained doctors.

What's Included

Metabolic Testing & Lab Work

Baseline and follow‑up labs measure blood glucose, lipid profiles and other metrics to tailor your plan.

Nutrition & Lifestyle Coaching

Registered dietitians build meal plans and teach strategies for sustained weight‑loss success.

Regular Check‑Ins

Monthly tele‑health or in‑person visits ensure accountability; we adjust medications and provide support for any challenges

Candidate Consideration

  • You’re ready to commit to lifestyle change and regular follow‑ups.
  • Not pregnant or breastfeeding; have no history of thyroid cancer or pancreatitis.
  • Comfortable self‑injecting a weekly medication (or have someone who can help).  

Real Experiences

“I can see my feet when I stand up. I don’t hurt in the morning… Now I have all this energy; I can keep up with my daughter. It’s amazing how much better I feel ”

– Sean

“I was tired of being tired. With the coaching and medication, I finally feel in control.  ” 

– Maria

Pricing & Coverage

  • During your consultation, we verify insurance benefits for GLP‑1 medications, discuss out‑of‑pocket costs and explore financing options.

  • We provide transparent pricing for program fees, lab work and medication (if not covered).

Frequently Asked Questions

What’s the difference between Wegovy® and Ozempic®? 

Both contain semaglutide, but Wegovy® is FDA‑approved for weight loss at a higher dose (2.4 mg vs 1 mg) Ozempic® is approved for type‑2 diabetes; we use it off‑label for weight loss under close supervision 

What about Mounjaro®? 

Mounjaro activates both GLP‑1 and GIP receptors, leading to potentially greater appetite suppression and weight loss 

How much weight can I expect to lose?

Clinical trials show an average loss of 15 % or more with semaglutide; tirzepatide studies show 15–22 %. Your results depend on adherence to medication and lifestyle changes. 

What happens if I stop taking the medication?

Weight regain can occur without healthy habits. That’s why we focus on building long‑term behaviors before tapering or discontinuing your prescription 

Are side effects common?

Eighty percent of patients reach their goal weight within 3 - 6 months. Sustaining results requires continued lifestyle changes, which is why accountability and coaching are built into the program. 

Ready to see if GLP‑1 therapy is right for you? 


Schedule your free consultation today and receive your eligibility assessment. 

Disclaimer: Medication is prescribed only after an evaluation by a qualified clinician. Individual results vary and are influenced by adherence, medical history, and lifestyle factors 

© 2025 Transform Weight Loss. All rights reserved.

GLP-1 Weight Loss

Real‑World Support for Real‑Life Results 

Our Mayo Clinic-trained team combines FDA - approved medications like Wegovy®, Ozempic®, Mounjaro® and Zepbound™ with metabolic testing, nutrition coaching and ongoing follow‑ups to help you lose weight safely and sustainably.

(Individual results vary. Our program is designed for long‑term success.)

Patient Portal & App 

Track medications, log meals, sync wearable devices and communicate with your care team. 

Who shouldn’t take GLP‑1 medications?


People with personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or pancreatitis should avoid these drugs. 


  • Dr. Peter Billing is founder of Transform Weight Loss

  • He is the first surgeon to perform Laparoscopic Sleeve Gastrectomy in an ambulatory surgical center (ASC) in 2008.

  • Considered the international expert for same day bariatric surgery in an ambulatory setting  

  • Has performed over 5000 bariatric procedures!

  • Is a frequent speaker and author with multiple peer reviewed clinical publications.



Transform Leadership

Learn More About GLP-1Learn More About GLP-1Learn More About GLP-1Learn More About GLP-1